This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
6o0l
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | '''Unreleased structure''' | ||
| - | + | ==crystal structure of BCL-2 G101V mutation with venetoclax== | |
| - | + | <StructureSection load='6o0l' size='340' side='right'caption='[[6o0l]], [[Resolution|resolution]] 2.20Å' scene=''> | |
| - | + | == Structural highlights == | |
| - | + | <table><tr><td colspan='2'>[[6o0l]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6O0L OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6O0L FirstGlance]. <br> | |
| - | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=LBM:4-[4-[[2-(4-chlorophenyl)-4,4-dimethyl-cyclohexen-1-yl]methyl]piperazin-1-yl]-~{N}-[4-(oxan-4-ylmethylamino)-3-[oxidanyl(oxidanylidene)-$l^{4}-azanyl]phenyl]sulfonyl-2-(1~{H}-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide'>LBM</scene>, <scene name='pdbligand=PEG:DI(HYDROXYETHYL)ETHER'>PEG</scene></td></tr> | |
| - | [[Category: | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6o0l FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6o0l OCA], [http://pdbe.org/6o0l PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6o0l RCSB], [http://www.ebi.ac.uk/pdbsum/6o0l PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6o0l ProSAT]</span></td></tr> |
| + | </table> | ||
| + | __TOC__ | ||
| + | </StructureSection> | ||
| + | [[Category: Large Structures]] | ||
| + | [[Category: Birkinshaw, R W]] | ||
| + | [[Category: Colman, P M]] | ||
| + | [[Category: Czabotar, P E]] | ||
| + | [[Category: Luo, C S]] | ||
| + | [[Category: Apoptosis]] | ||
| + | [[Category: Bcl-2]] | ||
| + | [[Category: Complex]] | ||
| + | [[Category: Fda approved drug complex]] | ||
| + | [[Category: Protein-protein interface inhibitor]] | ||
| + | [[Category: Resistance mutation]] | ||
| + | [[Category: Venetoclax]] | ||
Revision as of 06:53, 23 May 2019
crystal structure of BCL-2 G101V mutation with venetoclax
| |||||||||||
